Annual report [Section 13 and 15(d), not S-K Item 405]

Schedule of License Agreements (Details)

v3.25.1
Schedule of License Agreements (Details)
12 Months Ended
Dec. 31, 2024
Elion Oncology Inc [Member]  
Agreement Date Aug. 23, 2020
Amendment Date May 17, 2022
Ocuphire Pharma Inc [Member]  
Agreement Date Jun. 16, 2021
Aposense, Ltd. [Member]  
Agreement Date May 24, 2020
Yuhan Corporation [Member]  
Agreement Date Aug. 19, 2020
CoNCERT Pharmaceuticals, Inc [Member]  
Agreement Date Mar. 19, 2018